| pubmed-article:11129326 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11129326 | lifeskim:mentions | umls-concept:C0003250 | lld:lifeskim |
| pubmed-article:11129326 | lifeskim:mentions | umls-concept:C0334227 | lld:lifeskim |
| pubmed-article:11129326 | lifeskim:mentions | umls-concept:C0009511 | lld:lifeskim |
| pubmed-article:11129326 | lifeskim:mentions | umls-concept:C0205369 | lld:lifeskim |
| pubmed-article:11129326 | lifeskim:mentions | umls-concept:C0599894 | lld:lifeskim |
| pubmed-article:11129326 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:11129326 | pubmed:dateCreated | 2000-12-20 | lld:pubmed |
| pubmed-article:11129326 | pubmed:abstractText | The goal of this research is to determine the feasibility of an immunotherapeutic approach based on the use of monoclonal antibodies (mAb) to target complement activation fragments on opsonized cancer cells. | lld:pubmed |
| pubmed-article:11129326 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11129326 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11129326 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11129326 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11129326 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11129326 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11129326 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11129326 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11129326 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11129326 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11129326 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11129326 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11129326 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:11129326 | pubmed:issn | 0340-7004 | lld:pubmed |
| pubmed-article:11129326 | pubmed:author | pubmed-author:SutherlandW... | lld:pubmed |
| pubmed-article:11129326 | pubmed:author | pubmed-author:ChungL WLW | lld:pubmed |
| pubmed-article:11129326 | pubmed:author | pubmed-author:TaylorR PRP | lld:pubmed |
| pubmed-article:11129326 | pubmed:author | pubmed-author:YuanZ LZL | lld:pubmed |
| pubmed-article:11129326 | pubmed:author | pubmed-author:LindorferM... | lld:pubmed |
| pubmed-article:11129326 | pubmed:author | pubmed-author:SokoloffM HMH | lld:pubmed |
| pubmed-article:11129326 | pubmed:author | pubmed-author:NardinAA | lld:pubmed |
| pubmed-article:11129326 | pubmed:author | pubmed-author:BankovichA... | lld:pubmed |
| pubmed-article:11129326 | pubmed:author | pubmed-author:SolgaM DMD | lld:pubmed |
| pubmed-article:11129326 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11129326 | pubmed:volume | 49 | lld:pubmed |
| pubmed-article:11129326 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11129326 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11129326 | pubmed:pagination | 551-62 | lld:pubmed |
| pubmed-article:11129326 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:11129326 | pubmed:meshHeading | pubmed-meshheading:11129326... | lld:pubmed |
| pubmed-article:11129326 | pubmed:meshHeading | pubmed-meshheading:11129326... | lld:pubmed |
| pubmed-article:11129326 | pubmed:meshHeading | pubmed-meshheading:11129326... | lld:pubmed |
| pubmed-article:11129326 | pubmed:meshHeading | pubmed-meshheading:11129326... | lld:pubmed |
| pubmed-article:11129326 | pubmed:meshHeading | pubmed-meshheading:11129326... | lld:pubmed |
| pubmed-article:11129326 | pubmed:meshHeading | pubmed-meshheading:11129326... | lld:pubmed |
| pubmed-article:11129326 | pubmed:meshHeading | pubmed-meshheading:11129326... | lld:pubmed |
| pubmed-article:11129326 | pubmed:meshHeading | pubmed-meshheading:11129326... | lld:pubmed |
| pubmed-article:11129326 | pubmed:meshHeading | pubmed-meshheading:11129326... | lld:pubmed |
| pubmed-article:11129326 | pubmed:meshHeading | pubmed-meshheading:11129326... | lld:pubmed |
| pubmed-article:11129326 | pubmed:meshHeading | pubmed-meshheading:11129326... | lld:pubmed |
| pubmed-article:11129326 | pubmed:meshHeading | pubmed-meshheading:11129326... | lld:pubmed |
| pubmed-article:11129326 | pubmed:meshHeading | pubmed-meshheading:11129326... | lld:pubmed |
| pubmed-article:11129326 | pubmed:meshHeading | pubmed-meshheading:11129326... | lld:pubmed |
| pubmed-article:11129326 | pubmed:meshHeading | pubmed-meshheading:11129326... | lld:pubmed |
| pubmed-article:11129326 | pubmed:meshHeading | pubmed-meshheading:11129326... | lld:pubmed |
| pubmed-article:11129326 | pubmed:meshHeading | pubmed-meshheading:11129326... | lld:pubmed |
| pubmed-article:11129326 | pubmed:meshHeading | pubmed-meshheading:11129326... | lld:pubmed |
| pubmed-article:11129326 | pubmed:meshHeading | pubmed-meshheading:11129326... | lld:pubmed |
| pubmed-article:11129326 | pubmed:meshHeading | pubmed-meshheading:11129326... | lld:pubmed |
| pubmed-article:11129326 | pubmed:meshHeading | pubmed-meshheading:11129326... | lld:pubmed |
| pubmed-article:11129326 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:11129326 | pubmed:articleTitle | Targeting of cancer cells with monoclonal antibodies specific for C3b(i). | lld:pubmed |
| pubmed-article:11129326 | pubmed:affiliation | Department of Urology, University of Virginia School of Medicine, Charlottesville, USA. | lld:pubmed |
| pubmed-article:11129326 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11129326 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:11129326 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:11129326 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
